Teva Calls In Sanofi To Turbocharge Its Place In Blockbuster TL1A Inflammation Race :: Scrip
Teva & Barr Get Super-Sized
Teva files potential blockbuster migraine drug for FDA approval
Teva Pharmaceuticals appoints Richard Francis CEO | HealthCare Middle East & Africa Magazine
Teva Launches First Generic to Blockbuster Cancer Med
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva Stock Dives After Inking $1.5 Billion Deal For Inflammation Drug | Investor's Business Daily
After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace
 "Zydus faces stiff competition for blockbuster drug in US from Teva Pharma")
Zydus faces stiff competition for blockbuster drug in US from Teva Pharma
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters")
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
Teva seeks to reinvent itself as branded drug developer - Globes
Teva Pharmaceuticals: Value Play or Value Trap? | by Shivam Kollur | Medium
Teva to cut 14,000 jobs | Business | Chemistry World
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
A determined FDA takes down Teva's blockbuster | Evaluate
Teva's flagship drug Austedo scores new approval at the FDA
Teva plans to sell Irvine drug plant – Orange County Register
FOCUS-Generic drugmakers Teva and Sandoz make major push to biosimilars | Technology
Teva Weighs Sale of $2 Billion Active Ingredients Unit - BNN Bloomberg
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/JO75YOO42VEHBMB23A37IROB7A.jpg "Teva announces Philadelphia-area layoffs of more than 200")